Abstract:Rationale: Angiopoietin-like protein 3 (ANGPTL3) is a hepatically secreted protein and therapeutic target for reducing plasma triglyceride-rich lipoproteins and low-density lipoprotein cholesterol (LDL). Although ANGPTL3 modulates lipolytic pathways in the metabolism of circulating lipoproteins, its potential hepatocyte-specific role in very low-density lipoprotein (VLDL) assembly and secretion remains unknown. Methods: We established hepatocyte cell culture systems, including CRISPR/Cas9-edited ANGPTL3 “knock out” (KO) HepG2 cells and isogenic wild type controls. Radiolabeling was used to quantify apolipoprotein and triglyceride synthesis and secretion. LDL receptor (LDLR) expression and function were determined using western blot, flow cytometry, and confocal microscopy. Bulk RNA sequencing was used to compare global transcript-level changes between wild type and KO cells. Intracellular neutral lipid species were quantified by mass spectrometry-based targeted lipidomics. Results: We observed a statistically significant reduction of approximately 50% in apolipoprotein B100 (apoB100) secretion in ANGPTL3 KO HepG2 cells relative to wild type. We also observed statistically significant reductions ranging from 30-50% in the secretion of radiolabeled triglycerides from KO cells. Furthermore, KO cells showed increased LDLR expression and uptake of BODIPY-labeled LDL compared to wild type HepG2 cells. RNA sequencing demonstrated significantly altered expression of key genes within GO terms related to lipid metabolic processes and associated subcellular compartments. Targeted lipidomic analysis showed KO cells exhibited significant reductions in seven of 47 triglyceride species analyzed; overall, neutral lipid accumulation was not observed in KO cells. Conclusions: Our results point to an important intrahepatic role for ANGPTL3, suggesting ANGPTL3 deficiency leads to the production of fewer lipoprotein particles and corresponding adaptive changes in hepatic lipid metabolism.

Abstract 115: Angptl3 Deficiency Impairs Triglyceride-rich Lipoprotein Production and Produces Adaptive Changes in Hepatic Lipid Metabolism